JAMA Study Confirms Oncotype DX® Test Reliability Across Groups
Comprehensive review confirms that the Oncotype DX Breast Recurrence Score® test accurately predicts breast cancer outcomes and chemotherapy benefit for patients regardless of race or ethnicity...